LEVI-04

Asset

Soluble neurotrophin receptor fusion protein that binds neurotrophin-3 to reduce pain signaling.

Stage
Phase 2
Modality
Protein or enzyme
Target
NTF3
8
Indications
2
Trials
1
Developer

Named in the news on Nov 10, 2026. news.google.com

Indications

8

5 more

In the full profile

  • Target and mechanism1
  • Owner and partners1
  • Trials2
  • Evidence for its targets1
  • Competitors7
  • Signals2

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets